
NNNN P/E Ratio
P/E Ratio as of Jun 2, 2026: 196.21
Average179.75
Median183.14
Minimum153.15
Maximum210.38
196.21
19.67 (11.14%)past month
The P/E ratio for NNNN is 196.21 as of Jun 2, 2026. This represents a decrease of -54.60% compared to its 12-month average P/E ratio of 432.14. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Anbio Biotechnology Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Anbio Biotechnology Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Anbio Biotechnology Ltd to industry peers.
Anbio Biotechnology Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Anbio Biotechnology Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Anbio Biotechnology Ltd to industry peers.
NNNN P/E Ratio Insights
See Anbio Biotechnology Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NNNN
Order type
Buy in
Order amount
Est. shares
0 shares
NNNN P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 1, 2026 | $30.17 | 184.30 |
| May 1, 2026 | $28.90 | 176.54 |
| Apr 1, 2026 | $25.71 | 406.80 |
| Mar 2, 2026 | $22.91 | 362.5 |
| Feb 2, 2026 | $24.66 | 390.19 |
| Jan 2, 2026 | $29.48 | 466.46 |
NNNN End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 196.21 | -58.76% |
| 2025 | 475.79 | — |
FAQs About Anbio Biotechnology Ltd (NNNN) P/E ratio
The latest P/E ratio of NNNN is 196.21, as of Jun 2, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Anbio Biotechnology Ltd’s last 12-month average P/E ratio is 432.14, compared to its current P/E ratio of 196.21. This reflects a decrease of -54.60%.
Anbio Biotechnology Ltd’s current P/E ratio of 196.21 is lower than its last 12-month average P/E of 432.14. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Anbio Biotechnology Ltd’s average P/E ratio over the last 3 years is 154.4. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Anbio Biotechnology Ltd’s average P/E ratio over the last 5 years is 92.64. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.